{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:24:33Z","timestamp":1788967473966,"version":"build-2803163510"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10787-026-02371-7","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:18:28Z","timestamp":1787116708000},"page":"6059-6088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroinflammatory and molecular pathways in Alzheimer\u2019s disease: mechanistic crosstalk and emerging therapeutic opportunities"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1673-9985","authenticated-orcid":false,"given":"Abhay","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6352-0535","authenticated-orcid":false,"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dev","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2371_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-4939-6952-4_4","volume":"1598","author":"H Abou-El-Hassan","year":"2017","unstructured":"Abou-El-Hassan H, Sukhon F, Assaf EJ, Bahmad H, Abou-Abbass H, Jourdi H, Kobeissy FH (2017) Degradomics in neurotrauma: profiling traumatic brain injury. Methods Mol Biol 1598:65\u201399. https:\/\/doi.org\/10.1007\/978-1-4939-6952-4_4","journal-title":"Methods Mol Biol"},{"issue":"02","key":"2371_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4236\/nm.2011.22013","volume":"2","author":"I Ahmad","year":"2011","unstructured":"Ahmad I, Nirogi R (2011) 5-HT4 receptor agonists for the treatment of Alzheimer\u2019s diseases. Neurosci Med 2(02):87\u201392","journal-title":"Neurosci Med"},{"issue":"1","key":"2371_CR3","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1038\/s41598-025-89899-w","volume":"15","author":"F Amiri","year":"2025","unstructured":"Amiri F, Safiri S, Shamekh A, Ebrahimi A, Sullman MJ, Kolahi A-A (2025) Prevalence, deaths and disability-adjusted life years due to Alzheimer\u2019s disease and other dementias in Middle East and North Africa, 1990\u20132021. Sci Rep 15(1):7058","journal-title":"Sci Rep"},{"issue":"5","key":"2371_CR4","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1007\/s11357-024-01169-1","volume":"46","author":"E Anderton","year":"2024","unstructured":"Anderton E, Chamoli M, Bhaumik D, King CD, Xie X, Foulger A, Andersen JK, Schilling B, Lithgow GJ (2024) Amyloid beta accelerates age-related proteome-wide protein insolubility. GeroScience 46(5):4585\u20134602. https:\/\/doi.org\/10.1007\/s11357-024-01169-1","journal-title":"GeroScience"},{"key":"2371_CR5","doi-asserted-by":"publisher","first-page":"990354","DOI":"10.3389\/fnbeh.2022.990354","volume":"16","author":"C Aoki","year":"2022","unstructured":"Aoki C, Santiago AN (2022) Pathway-specific GABAergic inhibition contributes to the gain of resilience against anorexia-like behavior of adolescent female mice. Front Behav Neurosci 16:990354. https:\/\/doi.org\/10.3389\/fnbeh.2022.990354","journal-title":"Front Behav Neurosci"},{"issue":"4","key":"2371_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3233\/JAD-231318","volume":"98","author":"E Area-Gomez","year":"2024","unstructured":"Area-Gomez E, Schon EA (2024) Towards a unitary hypothesis of Alzheimer\u2019s disease pathogenesis. J Alzheimers Dis 98(4):1243\u20131275. https:\/\/doi.org\/10.3233\/JAD-231318","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2371_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","author":"As Association","year":"2015","unstructured":"Association As (2015) 2015 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 11(3):332\u2013384","journal-title":"Alzheimer\u2019s Dement"},{"key":"2371_CR8","doi-asserted-by":"publisher","first-page":"115374","DOI":"10.1016\/j.expneurol.2025.115374","volume":"392","author":"M Azmal","year":"2025","unstructured":"Azmal M, Paul JK, Prima FS, Haque ANMSNB, Meem M, Ghosh A (2025) Microglial dysfunction in Alzheimer\u2019s disease: mechanisms, emerging therapies, and future directions. Exp Neurol 392:115374. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115374","journal-title":"Exp Neurol"},{"issue":"9","key":"2371_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Dominantly Inherited Alzheimer, N. (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367(9):795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753","journal-title":"N Engl J Med"},{"key":"2371_CR10","doi-asserted-by":"crossref","unstructured":"Bell L, Stokar-Regenscheit N, Simonneau C, Augustin A, H\u00f6llbacher B, D\u2019Abate L, Ficek-Pascual J, Schneider K, Von Tell D, Zanini C (2024) ApoE4 disrupts intracellular trafficking and iron homeostasis in an improved iPSC-based model of human brain endothelial cells. bioRxiv, 2024.2009. 2003.610802","DOI":"10.1101\/2024.09.03.610802"},{"key":"2371_CR11","doi-asserted-by":"publisher","first-page":"1139357","DOI":"10.3389\/fncel.2023.1139357","volume":"17","author":"B Ben-Azu","year":"2023","unstructured":"Ben-Azu B, Del Re EC, VanderZwaag J, Carrier M, Keshavan M, Khakpour M, Tremblay ME (2023) Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia. Front Cell Neurosci 17:1139357. https:\/\/doi.org\/10.3389\/fncel.2023.1139357","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"2371_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/14737175.2023.2228491","volume":"23","author":"A Benussi","year":"2023","unstructured":"Benussi A, Borroni B (2023) Advances in the treatment and management of frontotemporal dementia. Expert Rev Neurother 23(7):621\u2013639","journal-title":"Expert Rev Neurother"},{"key":"2371_CR13","doi-asserted-by":"publisher","unstructured":"Biswas K (2023) Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation. J Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578180","DOI":"10.1016\/j.jneuroim.2023.578180"},{"key":"2371_CR14","doi-asserted-by":"crossref","unstructured":"Biswas S, Grover R, Reuther C, Poojari CS, Shaebani R, Nandakumar S, Gr\u00fcnewald M, Zablotsky A, Hub JS, Diez S (2025) Tau accelerates tubulin exchange in the microtubule lattice. Nat Phys 21(10):1616-28","DOI":"10.1038\/s41567-025-03003-7"},{"issue":"1","key":"2371_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","volume":"148","author":"P Botella Lucena","year":"2024","unstructured":"Botella Lucena P, Heneka MT (2024) Inflammatory aspects of Alzheimer\u2019s disease. Acta Neuropathol 148(1):31. https:\/\/doi.org\/10.1007\/s00401-024-02790-2","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2371_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-025-00811-6","volume":"20","author":"MA Bravo-Jimenez","year":"2025","unstructured":"Bravo-Jimenez MA, Sharma S, Karimi-Abdolrezaee S (2025) The integrated stress response in neurodegenerative diseases. Mol Neurodegener 20(1):20. https:\/\/doi.org\/10.1186\/s13024-025-00811-6","journal-title":"Mol Neurodegener"},{"issue":"13\u201314","key":"2371_CR17","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.addr.2008.06.003","volume":"60","author":"RD Brinton","year":"2008","unstructured":"Brinton RD (2008) Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer\u2019s disease. Adv Drug Deliv Rev 60(13\u201314):1504\u20131511. https:\/\/doi.org\/10.1016\/j.addr.2008.06.003","journal-title":"Adv Drug Deliv Rev"},{"key":"2371_CR18","doi-asserted-by":"publisher","first-page":"1552801","DOI":"10.3389\/fphar.2025.1552801","volume":"16","author":"Y Bu","year":"2025","unstructured":"Bu Y, Li S, Ye T, Wang Y, Song M, Chen J (2025) Volatile oil of Acori tatarinowii rhizoma: potential candidate drugs for mitigating dementia. Front Pharmacol 16:1552801. https:\/\/doi.org\/10.3389\/fphar.2025.1552801","journal-title":"Front Pharmacol"},{"issue":"17","key":"2371_CR19","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.3390\/jcm14176047","volume":"14","author":"JR Bumber","year":"2025","unstructured":"Bumber JR, Ra\u010dki V, Me\u017enari\u0107 S, Pel\u010di\u0107 G, Mr\u0161i\u0107-Pel\u010di\u0107 J (2025) Clinical significance of APOE4 genotyping: potential for personalized therapy and early diagnosis of Alzheimer\u2019s disease. J Clin Med 14(17):6047","journal-title":"J Clin Med"},{"issue":"1","key":"2371_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-clinpsy-050718-095432","volume":"15","author":"MI Butler","year":"2019","unstructured":"Butler MI, Cryan JF, Dinan TG (2019) Man and the microbiome: a new theory of everything? Annu Rev Clin Psychol 15(1):371\u2013398. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050718-095432","journal-title":"Annu Rev Clin Psychol"},{"issue":"3","key":"2371_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/jnc.15327","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler CA, Popescu AS, Kitchener EJA, Allendorf DH, Puigdellivol M, Brown GC (2021) Microglial phagocytosis of neurons in neurodegeneration, and its regulation. J Neurochem 158(3):621\u2013639. https:\/\/doi.org\/10.1111\/jnc.15327","journal-title":"J Neurochem"},{"issue":"9","key":"2371_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/antiox9090818","volume":"9","author":"DA Butterfield","year":"2020","unstructured":"Butterfield DA, Boyd-Kimball D (2020) Mitochondrial oxidative and nitrosative stress and Alzheimer disease. Antioxid (Basel) 9(9):818. https:\/\/doi.org\/10.3390\/antiox9090818","journal-title":"Antioxid (Basel)"},{"issue":"3","key":"2371_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20(3):148\u2013160. https:\/\/doi.org\/10.1038\/s41583-019-0132-6","journal-title":"Nat Rev Neurosci"},{"key":"2371_CR24","doi-asserted-by":"crossref","unstructured":"Cacabelos R (2025) New trends in Alzheimer\u2019s disease research: from molecular mechanisms to therapeutics, In: MDPI, 26: 7175","DOI":"10.3390\/ijms26157175"},{"issue":"2","key":"2371_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/biom13020313","volume":"13","author":"W Cai","year":"2023","unstructured":"Cai W, Wu T, Chen N (2023) The amyloid-beta clearance: from molecular targets to glial and neural cells. Biomolecules 13(2):313. https:\/\/doi.org\/10.3390\/biom13020313","journal-title":"Biomolecules"},{"issue":"2","key":"2371_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/brain\/awae230","volume":"148","author":"H Cai","year":"2025","unstructured":"Cai H, Zhao T, Pang Y, Fu X, Ren Z, Quan S, Jia L (2025) Systemic inflammatory markers in ageing, Alzheimer\u2019s disease and other dementias. Brain 148(2):480\u2013492. https:\/\/doi.org\/10.1093\/brain\/awae230","journal-title":"Brain"},{"key":"2371_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fncel.2019.00022","volume":"13","author":"M Calvo-Rodriguez","year":"2019","unstructured":"Calvo-Rodriguez M, Hernando-Perez E, Nunez L, Villalobos C (2019) Amyloid beta oligomers increase ER-Mitochondria Ca(2+) cross talk in young hippocampal neurons and exacerbate aging-induced intracellular Ca(2+) remodeling. Front Cell Neurosci 13:22. https:\/\/doi.org\/10.3389\/fncel.2019.00022","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"2371_CR28","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1038\/s41380-023-02140-w","volume":"28","author":"G Carello-Collar","year":"2023","unstructured":"Carello-Collar G, Bellaver B, Ferreira PCL, Ferrari-Souza JP, Ramos VG, Therriault J, Tissot C, De Bastiani MA, Soares C, Pascoal TA, Rosa-Neto P, Souza DO, Zimmer ER (2023) The GABAergic system in Alzheimer\u2019s disease: a systematic review with meta-analysis. Mol Psychiatry 28(12):5025\u20135036. https:\/\/doi.org\/10.1038\/s41380-023-02140-w","journal-title":"Mol Psychiatry"},{"key":"2371_CR29","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"J Castellano","year":"2011","unstructured":"Castellano J, Kim J, Stewart F, Jiang H, DeMattos R, Patterson B, Fagan A, Morris J, Mawuenyega K, Cruchaga C (2011) Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med 3:89ra57","journal-title":"Sci Transl Med"},{"issue":"6","key":"2371_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2217\/fnl.11.50","volume":"6","author":"C Cavanagh","year":"2011","unstructured":"Cavanagh C, Colby-Milley J, Farso M, Krantic S, Quirion R (2011) Early molecular and synaptic dysfunctions in the prodromal stages of Alzheimer\u2018s disease: focus on Tnf-\u03b1 and Il-1\u03b2. Future Neurol 6(6):757\u2013769","journal-title":"Future Neurol"},{"key":"2371_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuroscience.2021.08.003","volume":"474","author":"A Chagnot","year":"2021","unstructured":"Chagnot A, Barnes SR, Montagne A (2021) Magnetic resonance imaging of blood-brain barrier permeability in dementia. Neuroscience 474:14\u201329. https:\/\/doi.org\/10.1016\/j.neuroscience.2021.08.003","journal-title":"Neuroscience"},{"issue":"9","key":"2371_CR32","doi-asserted-by":"publisher","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen S, Cao Z, Nandi A, Counts N, Jiao L, Prettner K, Kuhn M, Seligman B, Tortorice D, Vigo D, Wang C, Bloom DE (2024) The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Glob Health 12(9):e1534\u2013e1543. https:\/\/doi.org\/10.1016\/S2214-109X(24)00264-X","journal-title":"Lancet Glob Health"},{"issue":"3","key":"2371_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.immuni.2026.02.004","volume":"59","author":"X Chen","year":"2026","unstructured":"Chen X, Holtzman DM, Colonna M (2026) Immunity in Alzheimer\u2019s disease: from mechanisms to therapies. Immunity 59(3):524\u2013541. https:\/\/doi.org\/10.1016\/j.immuni.2026.02.004","journal-title":"Immunity"},{"issue":"24","key":"2371_CR34","doi-asserted-by":"publisher","first-page":"11907","DOI":"10.3390\/ijms262411907","volume":"26","author":"M Chlubek","year":"2025","unstructured":"Chlubek M, Gassowska-Dobrowolska M, Kolasa A, Tarnowski M, Tomasiak P, Maruszewska A, Barczak K, Baranowska-Bosiacka I (2025) Disturbances in mitochondrial network, biogenesis, and mitochondria-mediated inflammatory responses in selected brain structures of rats exposed to lead (Pb) during prenatal and neonatal development. Int J Mol Sci 26(24):11907. https:\/\/doi.org\/10.3390\/ijms262411907","journal-title":"Int J Mol Sci"},{"issue":"s1","key":"2371_CR35","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.3233\/JAD-240146","volume":"101","author":"JRM Coimbra","year":"2024","unstructured":"Coimbra JRM, Resende R, Custodio JBA, Salvador JAR, Santos AE (2024) BACE1 inhibitors for Alzheimer\u2019s disease: current challenges and future perspectives. J Alzheimers Dis 101(s1):S53\u2013S78. https:\/\/doi.org\/10.3233\/JAD-240146","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2371_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn.2016.7","volume":"17","author":"M Colonna","year":"2016","unstructured":"Colonna M, Wang Y (2016) TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci 17(4):201\u2013207. https:\/\/doi.org\/10.1038\/nrn.2016.7","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"2371_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3892\/ijmm.2025.5613","volume":"56","author":"C Cong","year":"2025","unstructured":"Cong C, Cong H, Yao Y, Bai Y, Xu L (2025) Copper homeostasis and cuproptosis in Alzheimer\u2019s disease (Review). Int J Mol Med 56(5):172. https:\/\/doi.org\/10.3892\/ijmm.2025.5613","journal-title":"Int J Mol Med"},{"issue":"3","key":"2371_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"ADG Consortium","year":"2019","unstructured":"Consortium ADG (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet 51(3):414\u2013430","journal-title":"Nat Genet"},{"issue":"10","key":"2371_CR39","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/diagnostics13101682","volume":"13","author":"M Conte","year":"2023","unstructured":"Conte M, De Feo MS, Sidrak MMA, Corica F, Gorica J, Granese GM, Filippi L, De Vincentis G, Frantellizzi V (2023) Imaging of tauopathies with PET ligands: state of the art and future outlook. Diagnostics (Basel) 13(10):1682. https:\/\/doi.org\/10.3390\/diagnostics13101682","journal-title":"Diagnostics (Basel)"},{"issue":"6489","key":"2371_CR40","doi-asserted-by":"publisher","first-page":"eaat5314","DOI":"10.1126\/science.aat5314","volume":"368","author":"M Costa-Mattioli","year":"2020","unstructured":"Costa-Mattioli M, Walter P (2020) The integrated stress response: from mechanism to disease. Science 368(6489):eaat5314. https:\/\/doi.org\/10.1126\/science.aat5314","journal-title":"Science"},{"key":"2371_CR41","unstructured":"Cuestas Torres DM (2020) Synaptic transmission and alzheimer\u2019s disorder"},{"key":"2371_CR42","doi-asserted-by":"crossref","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2024) Alzheimer\u2019s disease drug development pipeline: 2024. Alzheimer\u2019s Dementia: Transl Res Clin Interv 10(2): e12465","DOI":"10.1002\/trc2.12465"},{"issue":"2","key":"2371_CR43","doi-asserted-by":"publisher","first-page":"e70098","DOI":"10.1002\/trc2.70098","volume":"11","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Zhou Y, Lee G, Zhong K, Fonseca J, Leisgang-Osse AM, Cheng F (2025) Alzheimer\u2019s disease drug development pipeline: 2025. Alzheimers Dement (N Y) 11(2):e70098. https:\/\/doi.org\/10.1002\/trc2.70098","journal-title":"Alzheimers Dement (N Y)"},{"key":"2371_CR44","unstructured":"da Concei\u00e7\u00e3o Pereira L (2023) The effects of radiation on amyloids and cells experimentally and modeled using the TOPAS framework Universidade de Lisboa (Portugal)]"},{"issue":"24","key":"2371_CR45","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1039\/c9sc06501f","volume":"11","author":"AJ Dear","year":"2020","unstructured":"Dear AJ, Meisl G, Saric A, Michaels TCT, Kjaergaard M, Linse S, Knowles TPJ (2020) Identification of on- and off-pathway oligomers in amyloid fibril formation. Chem Sci 11(24):6236\u20136247. https:\/\/doi.org\/10.1039\/c9sc06501f","journal-title":"Chem Sci"},{"issue":"6","key":"2371_CR46","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I (2020) The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181(6):1207\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2020.05.003","journal-title":"Cell"},{"issue":"17","key":"2371_CR47","doi-asserted-by":"publisher","first-page":"17294","DOI":"10.1074\/jbc.M500997200","volume":"280","author":"A Demuro","year":"2005","unstructured":"Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280(17):17294\u201317300","journal-title":"J Biol Chem"},{"key":"2371_CR48","doi-asserted-by":"publisher","first-page":"782617","DOI":"10.3389\/fnagi.2021.782617","volume":"13","author":"R Diaz-Espinoza","year":"2021","unstructured":"Diaz-Espinoza R (2021) Recent high-resolution structures of amyloids involved in neurodegenerative diseases. Front Aging Neurosci 13:782617. https:\/\/doi.org\/10.3389\/fnagi.2021.782617","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2371_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s42003-023-04539-1","volume":"6","author":"HN Do","year":"2023","unstructured":"Do HN, Devkota S, Bhattarai A, Wolfe MS, Miao Y (2023) Effects of presenilin-1 familial Alzheimer\u2019s disease mutations on gamma-secretase activation for cleavage of amyloid precursor protein. Commun Biol 6(1):174. https:\/\/doi.org\/10.1038\/s42003-023-04539-1","journal-title":"Commun Biol"},{"key":"2371_CR50","unstructured":"Dokalis N (2020) The impact of host microbiota on the innate immune system of the brain: a focus on metabolism and development Dissertation, Universit\u00e4t Freiburg, 2021]"},{"issue":"12","key":"2371_CR51","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1089\/ars.2011.4277","volume":"16","author":"H Du","year":"2012","unstructured":"Du H, Guo L, Yan SS (2012) Synaptic mitochondrial pathology in Alzheimer\u2019s disease. Antioxid Redox Signal 16(12):1467\u20131475. https:\/\/doi.org\/10.1089\/ars.2011.4277","journal-title":"Antioxid Redox Signal"},{"key":"2371_CR52","first-page":"14","volume":"12","author":"L Egefjord","year":"2012","unstructured":"Egefjord L, Gejl M, M\u00f8ller A, Br\u00e6ndgaard H, Gottrup H, Antropova O, M\u00f8ller N, Poulsen HE, Gjedde A, Brock B (2012) Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer\u00b4 s disease-protocol for a controlled, randomized double-blinded trial. Brain 12:14","journal-title":"Brain"},{"issue":"8","key":"2371_CR53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/cns.12095","volume":"19","author":"Z Esposito","year":"2013","unstructured":"Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A (2013) Amyloid \u03b2, glutamate, excitotoxicity in Alzheimer\u2019s disease: are we on the right track? CNS Neurosci Ther 19(8):549\u2013555","journal-title":"CNS Neurosci Ther"},{"key":"2371_CR54","first-page":"2009","volume":"20252001","author":"CA Essex","year":"2025","unstructured":"Essex CA, Bedggood MJ, Merenstein JL, Morgan C, Murray HC, Holdsworth SJ, Faull RL, Hume P, Theadom A, Pedersen M (2025) Magnetic susceptibility of the hippocampal subfields and basal ganglia in acute mild traumatic brain injury. medRxiv 20252001:2009\u201325320291","journal-title":"medRxiv"},{"issue":"6","key":"2371_CR56","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/hmg\/ddy017","volume":"27","author":"F Fang","year":"2018","unstructured":"Fang F, Yu Q, Arancio O, Chen D, Gore SS, Yan SS, Yan SF (2018) RAGE mediates Abeta accumulation in a mouse model of Alzheimer\u2019s disease via modulation of beta- and gamma-secretase activity. Hum Mol Genet 27(6):1002\u20131014. https:\/\/doi.org\/10.1093\/hmg\/ddy017","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2371_CR55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive MM, Caponio D, Dan X, Rocktaschel P, Croteau DL, Akbari M, Greig NH, Fladby T, Nilsen H, Cader MZ, Mattson MP, Tavernarakis N, Bohr VA (2019) Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22(3):401\u2013412. https:\/\/doi.org\/10.1038\/s41593-018-0332-9","journal-title":"Nat Neurosci"},{"key":"2371_CR57","unstructured":"Farhadizadeh M, Weymann M, Bla\u00df M, Kraus J, Gundler C, Walter S, Hempen N, Binder H, Binder N (2025) A systematic review of challenges and proposed solutions in modeling multimodal data. arXiv preprint arXiv:2505.06945"},{"issue":"1","key":"2371_CR58","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-020-71767-4","volume":"10","author":"JJ Fernandez-Valenzuela","year":"2020","unstructured":"Fernandez-Valenzuela JJ, Sanchez-Varo R, Munoz-Castro C, De Castro V, Sanchez-Mejias E, Navarro V, Jimenez S, Nunez-Diaz C, Gomez-Arboledas A, Moreno-Gonzalez I, Vizuete M, Davila JC, Vitorica J, Gutierrez A (2020) Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer\u2019s disease model. Sci Rep 10(1):14776. https:\/\/doi.org\/10.1038\/s41598-020-71767-4","journal-title":"Sci Rep"},{"key":"2371_CR59","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fnins.2018.00830","volume":"12","author":"LS Ferreira","year":"2018","unstructured":"Ferreira LS, Fernandes CS, Vieira MN, De Felice FG (2018a) Insulin resistance in Alzheimer\u2019s disease. Front NeuroSci 12:830","journal-title":"Front NeuroSci"},{"key":"2371_CR60","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fnins.2018.00830","volume":"12","author":"LSS Ferreira","year":"2018","unstructured":"Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG (2018b) Insulin Resistance in Alzheimer\u2019s disease. Front Neurosci 12:830. https:\/\/doi.org\/10.3389\/fnins.2018.00830","journal-title":"Front Neurosci"},{"issue":"1","key":"2371_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.7326\/M17-1529","volume":"168","author":"HA Fink","year":"2018","unstructured":"Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, Ratner E, Calvert C, Barclay TR, Brasure M, Nelson VA, Kane RL (2018) Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-Type dementia: a systematic review. Ann Intern Med 168(1):39\u201351. https:\/\/doi.org\/10.7326\/M17-1529","journal-title":"Ann Intern Med"},{"issue":"7662","key":"2371_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, Crowther RA, Ghetti B, Goedert M, Scheres SHW (2017) Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547(7662):185\u2013190. https:\/\/doi.org\/10.1038\/nature23002","journal-title":"Nature"},{"issue":"11","key":"2371_CR63","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1177\/0271678X18805317","volume":"39","author":"Y Fukumoto","year":"2019","unstructured":"Fukumoto Y, Tanaka KF, Parajuli B, Shibata K, Yoshioka H, Kanemaru K, Gachet C, Ikenaka K, Koizumi S, Kinouchi H (2019) Neuroprotective effects of microglial P2Y(1) receptors against ischemic neuronal injury. J Cereb Blood Flow Metab 39(11):2144\u20132156. https:\/\/doi.org\/10.1177\/0271678X18805317","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"2371_CR64","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1001\/jama.285.11.1475","volume":"285","author":"MI Geerlings","year":"2001","unstructured":"Geerlings MI, Ruitenberg A, Witteman JC, van Swieten JC, Hofman A, van Duijn CM, Breteler MM, Launer LJ (2001) Reproductive period and risk of dementia in postmenopausal women. JAMA 285(11):1475\u20131481. https:\/\/doi.org\/10.1001\/jama.285.11.1475","journal-title":"JAMA"},{"key":"2371_CR65","doi-asserted-by":"publisher","first-page":"100144","DOI":"10.1016\/j.nwnano.2025.100144","volume":"11","author":"A Ghosh","year":"2025","unstructured":"Ghosh A, Sarkar S, Mandal D, Orasugh JT, Ray SS, Chattopadhyay D (2025) Potential application of nanotechnology in Type-3 diabetes: bridging insulin resistance and neurodegeneration. Nano Trends 11:100144. https:\/\/doi.org\/10.1016\/j.nwnano.2025.100144","journal-title":"Nano Trends"},{"issue":"6700","key":"2371_CR66","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.adn5820","volume":"384","author":"X Guo","year":"2024","unstructured":"Guo X, Li H, Yan C, Lei J, Zhou R, Shi Y (2024) Molecular mechanism of substrate recognition and cleavage by human gamma-secretase. Science 384(6700):1091\u20131095. https:\/\/doi.org\/10.1126\/science.adn5820","journal-title":"Science"},{"issue":"2","key":"2371_CR67","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WAD.0000000000000623","volume":"38","author":"A Haghdel","year":"2024","unstructured":"Haghdel A, Smith N, Glodzik L, Li Y, Wang X, Crowder T, Zhu YS, Butler T, Blennow K, McIntire LB, Pahlajani S, Osborne J, Chiang G, de Leon M, Ivanidze J (2024) Evidence of pericyte damage in a cognitively normal cohort: association With CSF and PET biomarkers of Alzheimer disease. Alzheimer Dis Assoc Disord 38(2):107\u2013111. https:\/\/doi.org\/10.1097\/WAD.0000000000000623","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"2371_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40263-020-00781-x","volume":"35","author":"M Hallschmid","year":"2021","unstructured":"Hallschmid M (2021) Intranasal Insulin for Alzheimer\u2019s disease. CNS Drugs 35(1):21\u201337. https:\/\/doi.org\/10.1007\/s40263-020-00781-x","journal-title":"CNS Drugs"},{"issue":"1","key":"2371_CR69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13195-020-00686-3","volume":"12","author":"H Hampel","year":"2020","unstructured":"Hampel H, Lista S, Vanmechelen E, Zetterberg H, Giorgi FS, Galgani A, Blennow K, Caraci F, Das B, Yan R, Vergallo A, Alzheimer\u2019s Precision Medicine, I. (2020) beta-Secretase1 biological markers for Alzheimer\u2019s disease: state-of-art of validation and qualification. Alzheimers Res Ther 12(1):130. https:\/\/doi.org\/10.1186\/s13195-020-00686-3","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"2371_CR70","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1080\/15548627.2021.1907167","volume":"17","author":"S Han","year":"2021","unstructured":"Han S, Zhang M, Jeong YY, Margolis DJ, Cai Q (2021) The role of mitophagy in the regulation of mitochondrial energetic status in neurons. Autophagy 17(12):4182\u20134201. https:\/\/doi.org\/10.1080\/15548627.2021.1907167","journal-title":"Autophagy"},{"issue":"1","key":"2371_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/biom4010101","volume":"4","author":"F Hane","year":"2014","unstructured":"Hane F, Leonenko Z (2014) Effect of metals on kinetic pathways of amyloid-beta aggregation. Biomolecules 4(1):101\u2013116. https:\/\/doi.org\/10.3390\/biom4010101","journal-title":"Biomolecules"},{"key":"2371_CR72","doi-asserted-by":"publisher","first-page":"1554398","DOI":"10.3389\/fnagi.2025.1554398","volume":"17","author":"C He","year":"2025","unstructured":"He C, Chen B, Yang H, Zhou X (2025) The dual role of microglia in Alzheimer\u2019s disease: from immune regulation to pathological progression. Front Aging Neurosci 17:1554398. https:\/\/doi.org\/10.3389\/fnagi.2025.1554398","journal-title":"Front Aging Neurosci"},{"key":"2371_CR73","unstructured":"Hoeprich G (2016) The Role Of Kinesin-2 In Navigating Microtubule Obstacles. Implications For The Regulation Of Axonal Transport"},{"issue":"1","key":"2371_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13195-024-01407-w","volume":"16","author":"H Hong","year":"2024","unstructured":"Hong H, Hong L, Luo X, Zeng Q, Li K, Wang S, Jiaerken Y, Zhang R, Yu X, Zhang Y (2024) The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer\u2019s disease continuum participants. Alzheimers Res Ther 16(1):43","journal-title":"Alzheimers Res Ther"},{"key":"2371_CR75","doi-asserted-by":"publisher","first-page":"601320","DOI":"10.3389\/fphys.2020.601320","volume":"11","author":"MD Howe","year":"2020","unstructured":"Howe MD, McCullough LD, Urayama A (2020) The role of basement membranes in cerebral amyloid angiopathy. Front Physiol 11:601320. https:\/\/doi.org\/10.3389\/fphys.2020.601320","journal-title":"Front Physiol"},{"key":"2371_CR76","doi-asserted-by":"publisher","first-page":"149971","DOI":"10.1016\/j.brainres.2025.149971","volume":"1868","author":"A Ismail","year":"2025","unstructured":"Ismail A, Al-kuraishy HM, Al-Gareeb AI, Albuhadily AK, Yassen ASA, Alexiou A, Papadakis M, Batiha GE-S (2025) Astrocyte response in Alzheimer\u2019s disease: good or bad? Brain Res 1868:149971. https:\/\/doi.org\/10.1016\/j.brainres.2025.149971","journal-title":"Brain Res"},{"key":"2371_CR77","doi-asserted-by":"publisher","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Perez JM, Evans AC, Alzheimer\u2019s Disease Neuroimaging, I (2016) Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun 7(1):11934. https:\/\/doi.org\/10.1038\/ncomms11934.","DOI":"10.1038\/ncomms11934"},{"issue":"10","key":"2371_CR78","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1093\/brain\/awaa248","volume":"143","author":"CR Jack Jr","year":"2020","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Ferman TJ (2020) Predicting future rates of tau accumulation on PET. Brain 143(10):3136\u20133150","journal-title":"Brain"},{"issue":"5","key":"2371_CR79","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ymthe.2024.03.024","volume":"32","author":"RJ Jackson","year":"2024","unstructured":"Jackson RJ, Keiser MS, Meltzer JC, Fykstra DP, Dierksmeier SE, Hajizadeh S, Kreuzer J, Morris R, Melloni A, Nakajima T, Tecedor L, Ranum PT, Carrell E, Chen Y, Nishtar MA, Holtzman DM, Haas W, Davidson BL, Hyman BT (2024) APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease. Mol Ther 32(5):1373\u20131386. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.024","journal-title":"Mol Ther"},{"issue":"7409","key":"2371_CR80","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Stefansson K (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488(7409):96\u201399. https:\/\/doi.org\/10.1038\/nature11283","journal-title":"Nature"},{"issue":"11","key":"2371_CR81","doi-asserted-by":"publisher","first-page":"e0278276","DOI":"10.1371\/journal.pone.0278276","volume":"17","author":"JH Jung","year":"2022","unstructured":"Jung JH, Kim G, Byun MS, Lee JH, Yi D, Park H, Lee DY, Group KR (2022) Gut microbiome alterations in preclinical Alzheimer\u2019s disease. PLoS ONE 17(11):e0278276. https:\/\/doi.org\/10.1371\/journal.pone.0278276","journal-title":"PLoS ONE"},{"issue":"43","key":"2371_CR82","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1073\/pnas.1606171113","volume":"113","author":"L Katsouri","year":"2016","unstructured":"Katsouri L, Lim YM, Blondrath K, Eleftheriadou I, Lombardero L, Birch AM, Mirzaei N, Irvine EE, Mazarakis ND, Sastre M (2016) PPARgamma-coactivator-1alpha gene transfer reduces neuronal loss and amyloid-beta generation by reducing beta-secretase in an Alzheimer\u2019s disease model. Proc Natl Acad Sci U S A 113(43):12292\u201312297. https:\/\/doi.org\/10.1073\/pnas.1606171113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2371_CR83","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman SK, Sanders DW, Thomas TL, Ruchinskas AJ, Vaquer-Alicea J, Sharma AM, Miller TM, Diamond MI (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability. Vivo Neuron 92(4):796\u2013812. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.055","journal-title":"Vivo Neuron"},{"issue":"22","key":"2371_CR84","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.3390\/ijms252211955","volume":"25","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M, Kontek R (2024) Alzheimer\u2019s disease as type 3 diabetes: understanding the link and implications. Int J Mol Sci 25(22):11955","journal-title":"Int J Mol Sci"},{"key":"2371_CR85","doi-asserted-by":"publisher","first-page":"919712","DOI":"10.3389\/fnagi.2022.919712","volume":"14","author":"H Kim","year":"2022","unstructured":"Kim H, Devanand DP, Carlson S, Goldberg TE (2022) Apolipoprotein E genotype e2: neuroprotection and Its Limits. Front Aging Neurosci 14:919712. https:\/\/doi.org\/10.3389\/fnagi.2022.919712","journal-title":"Front Aging Neurosci"},{"key":"2371_CR86","doi-asserted-by":"publisher","first-page":"100365","DOI":"10.1016\/j.coemr.2022.100365","volume":"25","author":"I Klyubin","year":"2022","unstructured":"Klyubin I, Ondrejcak T, Hu N-W, Rowan MJ (2022) Glucocorticoids, synaptic plasticity and Alzheimer\u2019s disease. Curr Opin Endocr Metabolic Res 25:100365","journal-title":"Curr Opin Endocr Metabolic Res"},{"issue":"6","key":"2371_CR87","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","volume":"140","author":"N Korte","year":"2020","unstructured":"Korte N, Nortley R, Attwell D (2020) Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease. Acta Neuropathol 140(6):793\u2013810","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2371_CR88","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/ph18081117","volume":"18","author":"M Kruk-Slomka","year":"2025","unstructured":"Kruk-Slomka M, Kucel D, Malysz M, Machnikowska A, Orzelska-Gorka J, Biala G (2025) New approaches to the treatment of Alzheimer\u2019s disease. Pharmaceuticals (Basel) 18(8):1117. https:\/\/doi.org\/10.3390\/ph18081117","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2371_CR89","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12035-026-05909-6","volume":"63","author":"R Kumar","year":"2026","unstructured":"Kumar R, Patel S, Mishra PS, Srivastava S, Sridhar SB, Shareef J, Sahu R, Tariq M, Uddin J, Muhsinah AB (2026) From molecular networks to medicines: targeting complexity in Alzheimer\u2019s disease (AD) therapy. Mol Neurobiol 63(1):621. https:\/\/doi.org\/10.1007\/s12035-026-05909-6","journal-title":"Mol Neurobiol"},{"issue":"s1","key":"2371_CR90","doi-asserted-by":"publisher","first-page":"S379","DOI":"10.3233\/JAD-179944","volume":"64","author":"DJ Lane","year":"2018","unstructured":"Lane DJ, Ayton S, Bush AI (2018) Iron and Alzheimer\u2019s disease: an update on emerging mechanisms. J Alzheimer\u2019s Disease 64(s1):S379\u2013S395","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"3","key":"2371_CR91","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/cells14030168","volume":"14","author":"E Lee","year":"2025","unstructured":"Lee E, Chang Y (2025) Modulating neuroinflammation as a prospective therapeutic target in Alzheimer\u2019s disease. Cells 14(3):168","journal-title":"Cells"},{"issue":"1","key":"2371_CR92","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.1038\/s41598-024-60134-2","volume":"14","author":"MW Lee","year":"2024","unstructured":"Lee MW, Kim HW, Choe YS, Yang HS, Lee J, Lee H, Yong JH, Kim D, Lee M, Kang DW, Jeon SY, Son SJ, Lee YM, Kim HG, Kim REY, Lim HK (2024) A multimodal machine learning model for predicting dementia conversion in Alzheimer\u2019s disease. Sci Rep 14(1):12276. https:\/\/doi.org\/10.1038\/s41598-024-60134-2","journal-title":"Sci Rep"},{"issue":"3","key":"2371_CR93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nat Reviews Neurol 17(3):157\u2013172","journal-title":"Nat Reviews Neurol"},{"issue":"5","key":"2371_CR94","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hipo.22837","volume":"28","author":"T Li","year":"2018","unstructured":"Li T, Jiao JJ, H\u00f6lscher C, Wu MN, Zhang J, Tong JQ, Dong XF, Qu XS, Cao Y, Cai HY (2018) A novel GLP-1\/GIP\/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer\u2019s disease. Hippocampus 28(5):358\u2013372","journal-title":"Hippocampus"},{"key":"2371_CR95","doi-asserted-by":"publisher","first-page":"115218","DOI":"10.1016\/j.biopha.2023.115218","volume":"165","author":"Y Li","year":"2023","unstructured":"Li Y, Xu H, Wang H, Yang K, Luan J, Wang S (2023) TREM2: Potential therapeutic targeting of microglia for Alzheimer\u2019s disease. Biomed Pharmacother 165:115218. https:\/\/doi.org\/10.1016\/j.biopha.2023.115218","journal-title":"Biomed Pharmacother"},{"key":"2371_CR96","doi-asserted-by":"publisher","unstructured":"Li Y, Zhang C, Gao G, Shao X, Kang J, Yan X, Lin J, Qiao L (2025) Morphological changes in microglia in the mouse brain during postnatal development and obesity. Histol Histopathol. https:\/\/doi.org\/10.14670\/HH-18-976","DOI":"10.14670\/HH-18-976"},{"issue":"9","key":"2371_CR97","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.7150\/thno.53418","volume":"11","author":"C Liang","year":"2021","unstructured":"Liang C, Zou T, Zhang M, Fan W, Zhang T, Jiang Y, Cai Y, Chen F, Chen X, Sun Y, Zhao B, Wang Y, Cui L (2021) MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer\u2019s disease. Theranostics 11(9):4103\u20134121. https:\/\/doi.org\/10.7150\/thno.53418","journal-title":"Theranostics"},{"key":"2371_CR98","doi-asserted-by":"publisher","first-page":"845185","DOI":"10.3389\/fphar.2022.845185","volume":"13","author":"T Liang","year":"2022","unstructured":"Liang T, Zhang Y, Wu S, Chen Q, Wang L (2022) The role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets. Front Pharmacol 13:845185. https:\/\/doi.org\/10.3389\/fphar.2022.845185","journal-title":"Front Pharmacol"},{"issue":"1","key":"2371_CR99","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3233\/ADR-230181","volume":"8","author":"Y Liang","year":"2024","unstructured":"Liang Y, Dor\u00e9 V, Rowe CC, Krishnadas N (2024) Clinical evidence for GLP-1 receptor agonists in Alzheimer\u2019s disease: a systematic review. J Alzheimer\u2019s Disease Rep 8(1):777\u2013789","journal-title":"J Alzheimer\u2019s Disease Rep"},{"issue":"1","key":"2371_CR100","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/cells13010103","volume":"13","author":"C Lienard","year":"2024","unstructured":"Lienard C, Pintart A, Bomont P (2024) Neuronal autophagy: regulations and implications in health and disease. Cells 13(1):103. https:\/\/doi.org\/10.3390\/cells13010103","journal-title":"Cells"},{"issue":"2","key":"2371_CR101","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/acs.jmedchem.4c01322","volume":"68","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zheng L, Xu Y, Wang X, Li J, Zheng L, Liang G, Chen L (2025) Interleukin-1 receptor-associated Kinase 4 (IRAK4) degraders for treating inflammatory diseases: advances and prospects. J Med Chem 68(2):902\u2013914. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01322","journal-title":"J Med Chem"},{"issue":"12","key":"2371_CR104","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","volume":"57","author":"S Liu","year":"2020","unstructured":"Liu S, Gao J, Zhu M, Liu K, Zhang HL (2020) Gut microbiota and dysbiosis in Alzheimer\u2019s disease: implications for pathogenesis and treatment. Mol Neurobiol 57(12):5026\u20135043. https:\/\/doi.org\/10.1007\/s12035-020-02073-3","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2371_CR102","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1515\/revneuro-2023-0033","volume":"35","author":"L Liu","year":"2024","unstructured":"Liu L, Sun S, Kang W, Wu S, Lin L (2024a) A review of neuroimaging-based data-driven approach for Alzheimer\u2019s disease heterogeneity analysis. Rev Neurosci 35(2):121\u2013139. https:\/\/doi.org\/10.1515\/revneuro-2023-0033","journal-title":"Rev Neurosci"},{"issue":"9","key":"2371_CR103","doi-asserted-by":"publisher","first-page":"e30523","DOI":"10.1016\/j.heliyon.2024.e30523","volume":"10","author":"LC Liu","year":"2024","unstructured":"Liu LC, Liang JY, Liu YH, Liu B, Dong XH, Cai WH, Zhang N (2024b) The Intersection of cerebral cholesterol metabolism and Alzheimer\u2019s disease: Mechanisms and therapeutic prospects. Heliyon 10(9):e30523. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30523","journal-title":"Heliyon"},{"key":"2371_CR105","doi-asserted-by":"crossref","unstructured":"Liu T, Wu H, Wei J Bridging the Gap: The Neuro-immune Axis as a Key Player in Neurodegenerative Disorders: T., Liu et al (2025a) Neuro-immune Axis in Neurodegeneration. Neurosci Bull 41(10):1867-87","DOI":"10.1007\/s12264-025-01439-8"},{"issue":"2","key":"2371_CR106","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/13872877251378772","volume":"108","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen Y, Chen Z, Wan H, Wu C (2025b) Tau seeding activity in Alzheimer\u2019s disease: characteristics, factors, and applications. J Alzheimers Dis 108(2):487\u2013499. https:\/\/doi.org\/10.1177\/13872877251378772","journal-title":"J Alzheimers Dis"},{"issue":"10248","key":"2371_CR107","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimaki M, Larson EB, Ogunniyi A, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396(10248):413\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6","journal-title":"Lancet"},{"issue":"6","key":"2371_CR108","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S2213-8587(21)00269-2","volume":"10","author":"RA Lobo","year":"2022","unstructured":"Lobo RA, Gompel A (2022) Management of menopause: a view towards prevention. Lancet Diabetes Endocrinol 10(6):457\u2013470","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2371_CR109","doi-asserted-by":"publisher","first-page":"101145","DOI":"10.1016\/j.mtbio.2024.101145","volume":"27","author":"R Ma","year":"2024","unstructured":"Ma R, Mu Q, Xi Y, Liu G, Liu C (2024) Nanotechnology for tau pathology in Alzheimer\u2019s disease. Mater Today Bio 27:101145. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101145","journal-title":"Mater Today Bio"},{"key":"2371_CR110","doi-asserted-by":"publisher","first-page":"1576020","DOI":"10.3389\/fnagi.2025.1576020","volume":"17","author":"YN Ma","year":"2025","unstructured":"Ma YN, Hu X, Karako K, Song P, Tang W, Xia Y (2025) The potential and challenges of TREM2-targeted therapy in Alzheimer\u2019s disease: insights from the INVOKE-2 study. Front Aging Neurosci 17:1576020. https:\/\/doi.org\/10.3389\/fnagi.2025.1576020","journal-title":"Front Aging Neurosci"},{"key":"2371_CR111","unstructured":"Maciotta S, Meregalli\u00b9 M, Torrente Y (2018) The involvement of microRNAs in neurodegenerative. Regul RNAs Nerv Syst 193"},{"issue":"22","key":"2371_CR112","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3390\/cells12222595","volume":"12","author":"K Maiese","year":"2023","unstructured":"Maiese K (2023) Cornerstone cellular pathways for metabolic disorders and diabetes mellitus: non-coding RNAs, Wnt signaling, and AMPK. Cells 12(22):2595. https:\/\/doi.org\/10.3390\/cells12222595","journal-title":"Cells"},{"key":"2371_CR113","doi-asserted-by":"publisher","first-page":"1675209","DOI":"10.3389\/fgene.2025.1675209","volume":"16","author":"SK Makkar","year":"2025","unstructured":"Makkar SK (2025) Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives. Front Genet 16:1675209. https:\/\/doi.org\/10.3389\/fgene.2025.1675209","journal-title":"Front Genet"},{"key":"2371_CR114","doi-asserted-by":"publisher","first-page":"114778","DOI":"10.1016\/j.physbeh.2024.114778","volume":"290","author":"JN Manfredi","year":"2025","unstructured":"Manfredi JN, Gupta SK, Vyavahare S, Deak F, Lu X, Buddha L, Wankhade U, Lohakare J, Isales C, Fulzele S (2025) Gut microbiota dysbiosis in Alzheimer\u2019s disease (AD): Insights from human clinical studies and the mouse AD models. Physiol Behav 290:114778. https:\/\/doi.org\/10.1016\/j.physbeh.2024.114778","journal-title":"Physiol Behav"},{"issue":"2","key":"2371_CR115","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3233\/JAD-200306","volume":"78","author":"M Marizzoni","year":"2020","unstructured":"Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, Mombelli E, Mazzelli M, Luongo D, Naviglio D (2020) Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease 78(2):683\u2013697","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2371_CR116","unstructured":"Marne AS (2025) Age Related Cortisol Circadian Changes & Cognition. Georgia Institute of Technology"},{"issue":"7761","key":"2371_CR117","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X (2019) Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570(7761):332\u2013337","journal-title":"Nature"},{"issue":"3","key":"2371_CR118","doi-asserted-by":"publisher","first-page":"e00525","DOI":"10.1016\/j.neurot.2025.e00525","volume":"22","author":"KC McGill Percy","year":"2025","unstructured":"McGill Percy KC, Liu Z, Qi X (2025) Mitochondrial dysfunction in Alzheimer\u2019s disease: guiding the path to targeted therapies. Neurotherapeutics 22(3):e00525. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00525","journal-title":"Neurotherapeutics"},{"key":"2371_CR119","doi-asserted-by":"publisher","first-page":"1129036","DOI":"10.3389\/fnsyn.2023.1129036","volume":"15","author":"S Meftah","year":"2023","unstructured":"Meftah S, Gan J (2023) Alzheimer\u2019s disease as a synaptopathy: evidence for dysfunction of synapses during disease progression. Front Synaptic Neurosci 15:1129036","journal-title":"Front Synaptic Neurosci"},{"issue":"8","key":"2371_CR120","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/ars.2020.8070","volume":"34","author":"Y Mi","year":"2021","unstructured":"Mi Y, Qi G, Brinton RD, Yin F (2021) Mitochondria-targeted therapeutics for alzheimer\u2019s disease: the good, the bad, the potential. Antioxid Redox Signal 34(8):611\u2013630. https:\/\/doi.org\/10.1089\/ars.2020.8070","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2371_CR121","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13195-023-01173-1","volume":"15","author":"R Mohanty","year":"2023","unstructured":"Mohanty R, Ferreira D, Nordberg A, Westman E, Initiative AsDN (2023) Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer\u2019s disease continuum: biological and methodological perspectives from disease heterogeneity. Alzheimers Res Ther 15(1):37","journal-title":"Alzheimers Res Ther"},{"issue":"7806","key":"2371_CR122","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D\u2019Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Zlokovic BV (2020) APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581(7806):71\u201376. https:\/\/doi.org\/10.1038\/s41586-020-2247-3","journal-title":"Nature"},{"key":"2371_CR123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nlm.2013.07.002","volume":"105","author":"GP Morris","year":"2013","unstructured":"Morris GP, Clark IA, Zinn R, Vissel B (2013) Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research. Neurobiol Learn Mem 105:40\u201353. https:\/\/doi.org\/10.1016\/j.nlm.2013.07.002","journal-title":"Neurobiol Learn Mem"},{"issue":"6","key":"2371_CR124","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi S, Gaiteri C, Sullivan SE, White CC, Tasaki S, Xu J, Taga M, Klein H-U, Patrick E, Komashko V (2018) A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat Neurosci 21(6):811\u2013819","journal-title":"Nat Neurosci"},{"key":"2371_CR125","doi-asserted-by":"crossref","unstructured":"Mottaqi M, Zhang P, Xie L (2025) Integrating explainable AI with multiomics systems biology and EHR data mining for personalized drug repurposing in Alzheimer\u2019s disease","DOI":"10.1101\/2025.03.24.644676"},{"key":"2371_CR127","doi-asserted-by":"publisher","first-page":"e051871","DOI":"10.1002\/alz.051871","volume":"17","author":"CJ Mummery","year":"2021","unstructured":"Mummery CJ, Junge C, Kordasiewicz HB, Mignon L, Moore KM, Yun C, Baumann TL, Li D, Norris DA, Crean R (2021) Results of the first-in\u2010human, randomized, double\u2010blind, placebo\u2010controlled phase 1b study of lumbar intrathecal bolus administrations of antisense oligonucleotide (ISIS 814907; BIIB080) targeting tau mRNA in patients with mild Alzheimer\u2019s disease. Alzheimer\u2019s Dement 17:e051871","journal-title":"Alzheimer\u2019s Dement"},{"issue":"6","key":"2371_CR126","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","volume":"29","author":"CJ Mummery","year":"2023","unstructured":"Mummery CJ, Borjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S, Jonsson M, Schneider A, Rinne JO, Ludolph AC, Bodenschatz R, Kordasiewicz H, Swayze EE, Fitzsimmons B, Mignon L, Moore KM, Yun C, Baumann T, Li D, Lane RM (2023) Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial. Nat Med 29(6):1437\u20131447. https:\/\/doi.org\/10.1038\/s41591-023-02326-3","journal-title":"Nat Med"},{"issue":"1","key":"2371_CR128","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/JAD-215542","volume":"87","author":"R Nicsanu","year":"2022","unstructured":"Nicsanu R, Cervellati C, Benussi L, Squitti R, Zanardini R, Rosta V, Trentini A, Ferrari C, Saraceno C, Longobardi A (2022) Increased serum beta-secretase 1 activity is an early marker of Alzheimer\u2019s disease. J Alzheimer\u2019s Disease 87(1):433\u2013441","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"2371_CR129","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1038\/ncomms14727","volume":"8","author":"A Nobili","year":"2017","unstructured":"Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, Krashia P, Rizzo FR, Marino R, Federici M, De Bartolo P, Aversa D, Dell\u2019Acqua MC, Cordella A, Sancandi M, Keller F, Petrosini L, Puglisi-Allegra S, Mercuri NB, D\u2019Amelio M (2017) Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease. Nat Commun 8(1):14727. https:\/\/doi.org\/10.1038\/ncomms14727","journal-title":"Nat Commun"},{"key":"2371_CR130","unstructured":"Ochoa L (2022) Treatment with Nicotine derived Nitrosamine Ketone NNK Causes Disruption of Blood Brain Barrier. BBB and Microglia Activation in Mice"},{"key":"2371_CR131","unstructured":"Of GVANA (2019) Oligomannate For Mild To Moderate Alzheimer\u2019s Disease. Shanghai Green Valley Pharmaceuticals https:\/\/www.greenvalleypharma.com\/En\/Index\/pageView\/catid\/48\/id\/28. html"},{"issue":"15","key":"2371_CR132","doi-asserted-by":"publisher","first-page":"12498","DOI":"10.3390\/ijms241512498","volume":"24","author":"EO Olufunmilayo","year":"2023","unstructured":"Olufunmilayo EO, Holsinger RMD (2023) Roles of non-coding RNA in Alzheimer\u2019s disease pathophysiology. Int J Mol Sci 24(15):12498. https:\/\/doi.org\/10.3390\/ijms241512498","journal-title":"Int J Mol Sci"},{"key":"2371_CR133","doi-asserted-by":"publisher","first-page":"435469","DOI":"10.3389\/fnagi.2019.00043","volume":"11","author":"S Ouanes","year":"2019","unstructured":"Ouanes S, Popp J (2019) High cortisol and the risk of dementia and Alzheimer\u2019s disease: a review of the literature. Front Aging Neurosci 11:435469","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2371_CR134","doi-asserted-by":"publisher","first-page":"104","DOI":"10.34172\/bma.29","volume":"2","author":"AM Ozdemir","year":"2025","unstructured":"Ozdemir AM, Senoglu HL, Dastouri M (2025) miRNA-Loaded stem cell-derived exosomes in neuroregeneration: current insights and future perspectives. Biomed Adv 2(3):104\u2013130","journal-title":"Biomed Adv"},{"key":"2371_CR135","doi-asserted-by":"publisher","first-page":"1713391","DOI":"10.3389\/fnagi.2025.1713391","volume":"17","author":"S Pahal","year":"2025","unstructured":"Pahal S, Ganne A, Balasubramaniam M, Griffin ST, Reis S, R. J., Ayyadevara S (2025) The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer\u2019s disease. Front Aging Neurosci 17:1713391. https:\/\/doi.org\/10.3389\/fnagi.2025.1713391","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"2371_CR136","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y, Serrano GE, Leuzy A, Mattsson-Carlgren N, Strandberg O, Smith R, Villegas A, Sepulveda-Falla D, Chai X, Proctor NK, Beach TG, Blennow K, Hansson O (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease versus other neurodegenerative disorders. JAMA 324(8):772\u2013781. https:\/\/doi.org\/10.1001\/jama.2020.12134","journal-title":"JAMA"},{"issue":"8","key":"2371_CR137","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/jcm10081555","volume":"10","author":"A Patthy","year":"2021","unstructured":"Patthy A, Murai J, Hanics J, Pinter A, Zahola P, Hokfelt TGM, Harkany T, Alpar A (2021) Neuropathology of the brainstem to mechanistically understand and to treat Alzheimer\u2019s disease. J Clin Med 10(8):1555. https:\/\/doi.org\/10.3390\/jcm10081555","journal-title":"J Clin Med"},{"issue":"2","key":"2371_CR138","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/antiox13020240","volume":"13","author":"C Peggion","year":"2024","unstructured":"Peggion C, Cali T, Brini M (2024) Mitochondria dysfunction and neuroinflammation in neurodegeneration: Who comes first? Antioxid (Basel) 13(2):240. https:\/\/doi.org\/10.3390\/antiox13020240","journal-title":"Antioxid (Basel)"},{"key":"2371_CR139","unstructured":"Penalba L (2022) Novel Non-Linear Approaches to Understanding the Dynamic Brain: Knowledge from rsfMRI and EEG Studies. Nottingham Trent University (United Kingdom)]"},{"key":"2371_CR140","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.redox.2018.09.001","volume":"19","author":"MJ Perez","year":"2018","unstructured":"Perez MJ, Ponce DP, Aranguiz A, Behrens MI, Quintanilla RA (2018) Mitochondrial permeability transition pore contributes to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer\u2019s disease. Redox Biol 19:290\u2013300. https:\/\/doi.org\/10.1016\/j.redox.2018.09.001","journal-title":"Redox Biol"},{"issue":"1","key":"2371_CR141","doi-asserted-by":"publisher","first-page":"fcae460","DOI":"10.1093\/braincomms\/fcae460","volume":"7","author":"L Pini","year":"2025","unstructured":"Pini L, Lista S, Griffa A, Allali G, Imbimbo BP (2025) Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs? Brain Commun 7(1):fcae460","journal-title":"Brain Commun"},{"issue":"22","key":"2371_CR142","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2174\/092986705774370664","volume":"12","author":"A Porcheddu","year":"2005","unstructured":"Porcheddu A, Giacomelli G (2005) Peptide nucleic acids (PNAs), a chemical overview. Curr Med Chem 12(22):2561\u20132599","journal-title":"Curr Med Chem"},{"key":"2371_CR143","unstructured":"Quillen DJ (2022) IL6 transsignaling in Alzheimer\u2019s disease. Wake Forest University"},{"issue":"7","key":"2371_CR144","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3390\/biomedicines12071390","volume":"12","author":"Y Ratan","year":"2024","unstructured":"Ratan Y, Rajput A, Pareek A, Pareek A, Kaur R, Sonia S, Kumar R, Singh G (2024) Recent advances in biomolecular patho-mechanistic pathways behind the development and progression of diabetic neuropathy. Biomedicines 12(7):1390. https:\/\/doi.org\/10.3390\/biomedicines12071390","journal-title":"Biomedicines"},{"issue":"2","key":"2371_CR145","doi-asserted-by":"publisher","first-page":"e9665","DOI":"10.15252\/emmm.201809665","volume":"11","author":"N Reichenbach","year":"2019","unstructured":"Reichenbach N, Delekate A, Plescher M, Schmitt F, Krauss S, Blank N, Halle A, Petzold GC (2019) Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer\u2019s disease model. EMBO Mol Med 11(2):e9665. https:\/\/doi.org\/10.15252\/emmm.201809665","journal-title":"EMBO Mol Med"},{"issue":"14","key":"2371_CR146","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ, Study M, G (2003) Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 348(14):1333\u20131341. https:\/\/doi.org\/10.1056\/NEJMoa013128","journal-title":"N Engl J Med"},{"issue":"7","key":"2371_CR147","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cells9071717","volume":"9","author":"JA Rodriguez-Gomez","year":"2020","unstructured":"Rodriguez-Gomez JA, Kavanagh E, Engskog-Vlachos P, Engskog MKR, Herrera AJ, Espinosa-Oliva AM, Joseph B, Hajji N, Venero JL, Burguillos MA (2020) Microglia: agents of the CNS pro-inflammatory response. Cells 9(7):1717. https:\/\/doi.org\/10.3390\/cells9071717","journal-title":"Cells"},{"key":"2371_CR148","doi-asserted-by":"publisher","unstructured":"Ruan E, Lin J, Chen Z, Sheng Q, Chen L, He J, Duan X, Qin Y, Xing T, Yang S, Pan M, Guo X, Yin P, Li XJ, Jiang H, Li S, Yang S (2025) Mutant THAP11 causes cerebellar neurodegeneration and triggers TREM2-mediated microglial activation in mice. J Clin Invest . https:\/\/doi.org\/10.1172\/JCI178349","DOI":"10.1172\/JCI178349"},{"issue":"17","key":"2371_CR149","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3390\/cells14171363","volume":"14","author":"P Rzeczycki","year":"2025","unstructured":"Rzeczycki P, Peciak O, Plust M, Drozdzik M (2025) Molecular aspects of geriatric pharmacotherapy. Cells 14(17):1363. https:\/\/doi.org\/10.3390\/cells14171363","journal-title":"Cells"},{"key":"2371_CR150","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ibneur.2024.11.004","volume":"17","author":"S S","year":"2024","unstructured":"S S, Rajendran LSD, P., N, H., Singh S, A (2024) Exploring the potential of probiotics in Alzheimer\u2019s disease and gut dysbiosis. IBRO Neurosci Rep 17:441\u2013455. https:\/\/doi.org\/10.1016\/j.ibneur.2024.11.004","journal-title":"IBRO Neurosci Rep"},{"issue":"11","key":"2371_CR151","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2025.3217","volume":"82","author":"G Salvado","year":"2025","unstructured":"Salvado G, Janelidze S, Bali D, Dolado AO, Therriault J, Brum WS, Pichet Binette A, Stomrud E, Mattsson-Carlgren N, Palmqvist S, Coomans EM, Teunissen CE, van der Flier WM, Rahmouni N, Benzinger TLS, Gispert JD, Blennow K, Dore V, Feizpour A, Groups P-AS (2025) Plasma phosphorylated tau 217 to identify preclinical Alzheimer disease. JAMA Neurol 82(11):1122\u20131134. https:\/\/doi.org\/10.1001\/jamaneurol.2025.3217","journal-title":"JAMA Neurol"},{"key":"2371_CR152","unstructured":"Salwierz P (2025) Assessing the role of past depression in individuals with and without Alzheimer\u2019s disease using cerebrospinal fluid and neuroimaging biomarkers. University of Toronto (Canada)"},{"issue":"5","key":"2371_CR153","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/brain\/awae035","volume":"147","author":"P Sanchez-Juan","year":"2024","unstructured":"Sanchez-Juan P, Valeriano-Lorenzo E, Ruiz-Gonzalez A, Pastor AB, Lara R, Lopez-Gonzalez H, Zea-Sevilla F, Valenti MA, Frades M, Ruiz B, Saiz P, Burgueno-Garcia L, Calero I, Del Ser M, T., Rabano A (2024) Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles. Brain 147(5):1667\u20131679. https:\/\/doi.org\/10.1093\/brain\/awae035","journal-title":"Brain"},{"issue":"15","key":"2371_CR154","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.3390\/ijms25158354","volume":"25","author":"C Saraceno","year":"2024","unstructured":"Saraceno C, Cervellati C, Trentini A, Crescenti D, Longobardi A, Geviti A, Bonfiglio NS, Bellini S, Nicsanu R, Fostinelli S (2024) Serum Beta-secretase 1 activity is a potential marker for the differential diagnosis between Alzheimer\u2019s disease and frontotemporal dementia: a pilot study. Int J Mol Sci 25(15):8354","journal-title":"Int J Mol Sci"},{"issue":"10284","key":"2371_CR155","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590","journal-title":"Lancet"},{"issue":"1","key":"2371_CR156","doi-asserted-by":"publisher","first-page":"13249","DOI":"10.1038\/ncomms13249","volume":"7","author":"TW Schmitz","year":"2016","unstructured":"Schmitz TW, Spreng N, R., Neuroimaging AD, I (2016) Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer\u2019s pathology. Nat Commun 7(1):13249. https:\/\/doi.org\/10.1038\/ncomms13249","journal-title":"Nat Commun"},{"issue":"10","key":"2371_CR157","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.lanhl.2024.07.013","volume":"5","author":"M Scholl","year":"2024","unstructured":"Scholl M, Verberk IMW, Campo D, Delaby M, Therriault C, Chong J, Palmqvist JR, S., Alcolea D (2024) Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease. Lancet Healthy Longev 5(10):100630. https:\/\/doi.org\/10.1016\/j.lanhl.2024.07.013","journal-title":"Lancet Healthy Longev"},{"issue":"6","key":"2371_CR158","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608","journal-title":"EMBO Mol Med"},{"issue":"3","key":"2371_CR159","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/biom11030354","volume":"11","author":"T Shacham","year":"2021","unstructured":"Shacham T, Patel C, Lederkremer GZ (2021) PERK pathway and neurodegenerative disease: To inhibit or to activate? Biomolecules 11(3):354. https:\/\/doi.org\/10.3390\/biom11030354","journal-title":"Biomolecules"},{"issue":"2","key":"2371_CR160","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/10738584241254118","volume":"31","author":"Q Shi","year":"2025","unstructured":"Shi Q, Gutierrez RA, Bhat MA (2025a) Microglia, Trem2, and neurodegeneration. Neuroscientist 31(2):159\u2013176","journal-title":"Neuroscientist"},{"issue":"2","key":"2371_CR161","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/10738584241254118","volume":"31","author":"Q Shi","year":"2025","unstructured":"Shi Q, Gutierrez RA, Bhat MA (2025b) Microglia, Trem2, and neurodegeneration. Neuroscientist 31(2):159\u2013176. https:\/\/doi.org\/10.1177\/10738584241254118","journal-title":"Neuroscientist"},{"key":"2371_CR162","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3389\/fneur.2019.01125","volume":"10","author":"A Shoeibi","year":"2019","unstructured":"Shoeibi A, Olfati N, Litvan I (2019) Frontrunner in translation: progressive supranuclear palsy. Front Neurol 10:1125. https:\/\/doi.org\/10.3389\/fneur.2019.01125","journal-title":"Front Neurol"},{"issue":"6","key":"2371_CR163","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Nery ESM (2023) Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330(6):512\u2013527","journal-title":"JAMA"},{"issue":"5","key":"2371_CR164","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/j.1471-4159.2007.04907.x","volume":"103","author":"D Sirk","year":"2007","unstructured":"Sirk D, Zhu Z, Wadia JS, Shulyakova N, Phan N, Fong J, Mills LR (2007) Chronic exposure to sub-lethal beta-amyloid (Abeta) inhibits the import of nuclear-encoded proteins to mitochondria in differentiated PC12 cells. J Neurochem 103(5):1989\u20132003. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04907.x","journal-title":"J Neurochem"},{"issue":"8","key":"2371_CR165","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/pharmaceutics15082051","volume":"15","author":"N Siwecka","year":"2023","unstructured":"Siwecka N, Saramowicz K, Galita G, Rozp\u0119dek-Kami\u0144ska W, Majsterek I (2023) Inhibition of protein aggregation and endoplasmic reticulum stress as a targeted therapy for \u03b1-synucleinopathy. Pharmaceutics 15(8):2051","journal-title":"Pharmaceutics"},{"issue":"1","key":"2371_CR166","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0925-4439(00)00040-5","volume":"1502","author":"MA Smith","year":"2000","unstructured":"Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2000) Oxidative stress in Alzheimer\u2019s disease. Biochim Biophys Acta 1502(1):139\u2013144. https:\/\/doi.org\/10.1016\/s0925-4439(00)00040-5","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2371_CR167","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1038\/s41467-021-23243-4","volume":"12","author":"RG Smith","year":"2021","unstructured":"Smith RG, Pishva E, Shireby G, Smith AR, Roubroeks JAY, Hannon E, Wheildon G, Mastroeni D, Gasparoni G, Riemenschneider M, Giese A, Sharp AJ, Schalkwyk L, Haroutunian V, Viechtbauer W, van den Hove DLA, Weedon M, Brokaw D, Francis PT, Lunnon K (2021) A meta-analysis of epigenome-wide association studies in Alzheimer\u2019s disease highlights novel differentially methylated loci across cortex. Nat Commun 12(1):3517. https:\/\/doi.org\/10.1038\/s41467-021-23243-4","journal-title":"Nat Commun"},{"key":"2371_CR168","doi-asserted-by":"publisher","first-page":"1149618","DOI":"10.3389\/fneur.2023.1149618","volume":"14","author":"R Solanki","year":"2023","unstructured":"Solanki R, Karande A, Ranganathan P (2023) Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration. Front Neurol 14:1149618. https:\/\/doi.org\/10.3389\/fneur.2023.1149618","journal-title":"Front Neurol"},{"issue":"4","key":"2371_CR169","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3233\/JAD-200473","volume":"76","author":"E Solis Jr","year":"2020","unstructured":"Solis E Jr, Hascup KN, Hascup ER (2020) Alzheimer\u2019s disease: the link between amyloid-\u03b2 and neurovascular dysfunction. J Alzheimer\u2019s Disease 76(4):1179\u20131198","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2371_CR170","unstructured":"Sousa N, Sotiropoulos I Chrysoula Dioli, Georgia Papadimitriou, Anastasia Megalokonomou, Carlos Marques. GeNeDis 2022, 303"},{"issue":"3","key":"2371_CR171","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaneurol.2020.4857","volume":"78","author":"R Sperling","year":"2021","unstructured":"Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Romano G (2021) Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical alzheimer disease: a truncated randomized phase 2b\/3 clinical trial. JAMA Neurol 78(3):293\u2013301. https:\/\/doi.org\/10.1001\/jamaneurol.2020.4857","journal-title":"JAMA Neurol"},{"issue":"19","key":"2371_CR172","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1073\/pnas.1506242112","volume":"112","author":"L Sun","year":"2015","unstructured":"Sun L, Zhao L, Yang G, Yan C, Zhou R, Zhou X, Xie T, Zhao Y, Wu S, Li X, Shi Y (2015) Structural basis of human gamma-secretase assembly. Proc Natl Acad Sci U S A 112(19):6003\u20136008. https:\/\/doi.org\/10.1073\/pnas.1506242112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2371_CR173","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ijmm.2025.5580","volume":"56","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wei K, Liao X, Wang J, Gao L, Pang B (2025) Lipid metabolism in microglia: emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review). Int J Mol Med 56(3):139. https:\/\/doi.org\/10.3892\/ijmm.2025.5580","journal-title":"Int J Mol Med"},{"issue":"5","key":"2371_CR174","doi-asserted-by":"publisher","first-page":"afaf130","DOI":"10.1093\/ageing\/afaf130","volume":"54","author":"HK Sung","year":"2025","unstructured":"Sung HK, Wu F, Afanasyeva Y, Koenig KL, Clendenen TV, Zeleniuch-Jacquotte A, Chen Y (2025) Body mass index changes and trajectories from midlife to late-life: association with subjective cognitive complaints in a 30-year Women\u2019s cohort study. Age Ageing 54(5):afaf130. https:\/\/doi.org\/10.1093\/ageing\/afaf130","journal-title":"Age Ageing"},{"issue":"3","key":"2371_CR175","doi-asserted-by":"publisher","first-page":"e14406","DOI":"10.1111\/acel.14406","volume":"24","author":"Z Suo","year":"2025","unstructured":"Suo Z, Xiao T, Qu Y, Zheng Y, Xu W, Zhou B, Yang J, Yu J, Zheng H, Ni C (2025) Aged hippocampal single-cell atlas screening unveils disrupted neuroglial system in postoperative cognitive impairment. Aging Cell 24(3):e14406. https:\/\/doi.org\/10.1111\/acel.14406","journal-title":"Aging Cell"},{"issue":"1","key":"2371_CR176","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1567205017666200212155234","volume":"17","author":"P Suss","year":"2020","unstructured":"Suss P, Schlachetzki JCM (2020) Microglia in Alzheimer\u2019s disease. Curr Alzheimer Res 17(1):29\u201343. https:\/\/doi.org\/10.2174\/1567205017666200212155234","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"2371_CR177","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH (2018) Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimers Dis 62(3):1403\u20131416. https:\/\/doi.org\/10.3233\/JAD-170585","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2371_CR178","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cell.2017.07.004","volume":"170","author":"M Szaruga","year":"2017","unstructured":"Szaruga M, Munteanu B, Lismont S, Veugelen S, Horr\u00e9 K, Mercken M, Saido TC, Ryan NS, De Vos T, Savvides SN (2017) Alzheimer\u2019s-causing mutations shift A\u03b2 length by destabilizing \u03b3-secretase-A\u03b2n interactions. Cell 170(3):443\u2013456 e414","journal-title":"Cell"},{"issue":"11","key":"2371_CR179","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1002\/alz.14237","volume":"20","author":"PN Tariot","year":"2024","unstructured":"Tariot PN, Riviere ME, Salloway S, Burns JM, Snaedal JG, Borowsky B, Lopez CL, Liu F, Rouzade-Dominguez ML, Cazorla P, Mousseau MC, Arkuszewski M, Ricart J, Viglietta V, Sui Y, Caputo A, Langbaum JB, Reiman EM, Graf A (2024) Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer\u2019s Prevention Initiative (API) generation studies. Alzheimers Dement 20(11):7745\u20137761. https:\/\/doi.org\/10.1002\/alz.14237","journal-title":"Alzheimers Dement"},{"key":"2371_CR180","doi-asserted-by":"publisher","first-page":"966019","DOI":"10.3389\/fnins.2022.966019","volume":"16","author":"S Thellung","year":"2022","unstructured":"Thellung S, Corsaro A, Dellacasagrande I, Nizzari M, Zambito M, Florio T (2022) Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets. Front Neurosci 16:966019. https:\/\/doi.org\/10.3389\/fnins.2022.966019","journal-title":"Front Neurosci"},{"issue":"1","key":"2371_CR181","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41467-018-03509-0","volume":"9","author":"TA Thibaudeau","year":"2018","unstructured":"Thibaudeau TA, Anderson RT, Smith DM (2018) A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat Commun 9(1):1097. https:\/\/doi.org\/10.1038\/s41467-018-03509-0","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"2371_CR182","doi-asserted-by":"publisher","first-page":"33S","DOI":"10.2967\/jnumed.121.263198","volume":"63","author":"S Tiepolt","year":"2022","unstructured":"Tiepolt S, Meyer PM, Patt M, Deuther-Conrad W, Hesse S, Barthel H, Sabri O (2022) PET imaging of cholinergic neurotransmission in neurodegenerative disorders. J Nucl Med 63(Suppl 1):33S\u201344S. https:\/\/doi.org\/10.2967\/jnumed.121.263198","journal-title":"J Nucl Med"},{"issue":"3","key":"2371_CR183","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-210397","volume":"88","author":"S Tok","year":"2022","unstructured":"Tok S, Ahnaou A, Drinkenburg W (2022) Functional neurophysiological biomarkers of early-stage Alzheimer\u2019s disease: a perspective of network hyperexcitability in disease progression. J Alzheimers Dis 88(3):809\u2013836. https:\/\/doi.org\/10.3233\/JAD-210397","journal-title":"J Alzheimers Dis"},{"issue":"21","key":"2371_CR184","doi-asserted-by":"publisher","first-page":"11316","DOI":"10.3390\/app152111316","volume":"15","author":"M Usman","year":"2025","unstructured":"Usman M, Ashebir S, Okey-Mbata C, Yun Y, Kim S (2025) Neuroengineering frontiers: a selective review of neural interfaces, brain\u2013machine interactions, and artificial intelligence in neurodegenerative diseases. Appl Sci 15(21):11316","journal-title":"Appl Sci"},{"issue":"1","key":"2371_CR185","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.1038\/s41467-025-66728-2","volume":"16","author":"M Valletta","year":"2025","unstructured":"Valletta M, Vetrano DL, Gregorio C, Rizzuto D, Winblad B, Canevelli M, Andersson S, Dale M, Fredolini C, Laukka EJ, Fratiglioni L, Grande G (2025) Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community. Nat Commun 16(1):10412. https:\/\/doi.org\/10.1038\/s41467-025-66728-2","journal-title":"Nat Commun"},{"issue":"1","key":"2371_CR186","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321","journal-title":"N Engl J Med"},{"issue":"7685","key":"2371_CR187","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, Griep A, Gelpi E, Beilharz M, Riedel D, Golenbock DT, Geyer M, Walter J, Latz E, Heneka MT (2017) Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer\u2019s disease. Nature 552(7685):355\u2013361. https:\/\/doi.org\/10.1038\/nature25158","journal-title":"Nature"},{"issue":"12","key":"2371_CR188","doi-asserted-by":"publisher","first-page":"e0146127","DOI":"10.1371\/journal.pone.0146127","volume":"10","author":"A Verheyen","year":"2015","unstructured":"Verheyen A, Diels A, Dijkmans J, Oyelami T, Meneghello G, Mertens L, Versweyveld S, Borgers M, Buist A, Peeters P, Cik M (2015) Using human iPSC-derived neurons to model TAU aggregation. PLoS ONE 10(12):e0146127. https:\/\/doi.org\/10.1371\/journal.pone.0146127","journal-title":"PLoS ONE"},{"issue":"4","key":"2371_CR189","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1210\/er.2016-1007","volume":"37","author":"A Villa","year":"2016","unstructured":"Villa A, Vegeto E, Poletti A, Maggi A (2016) Estrogens, neuroinflammation, and neurodegeneration. Endocr Rev 37(4):372\u2013402. https:\/\/doi.org\/10.1210\/er.2016-1007","journal-title":"Endocr Rev"},{"issue":"1","key":"2371_CR190","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/jpm12010029","volume":"12","author":"C Villa","year":"2022","unstructured":"Villa C, Rivellini E, Lavitrano M, Combi R (2022) Can SARS-CoV-2 infection exacerbate Alzheimer\u2019s disease? An overview of shared risk factors and pathogenetic mechanisms. J Personalized Med 12(1):29","journal-title":"J Personalized Med"},{"key":"2371_CR191","doi-asserted-by":"publisher","first-page":"1021796","DOI":"10.3389\/fendo.2022.1021796","volume":"13","author":"P Villaseca","year":"2022","unstructured":"Villaseca P, Cisternas P, Inestrosa NC (2022) Menopause and development of Alzheimer\u2019s disease: roles of neural glucose metabolism and Wnt signaling. Front Endocrinol (Lausanne) 13:1021796. https:\/\/doi.org\/10.3389\/fendo.2022.1021796","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2371_CR193","unstructured":"Wang L (2022) Neural Cytoskeleton Modulation After Transient Ischemic Attack and Region-Specific Brain Metabolism Insights. University of North Texas Health Science Center at Fort Worth"},{"issue":"9","key":"2371_CR194","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/life11090938","volume":"11","author":"P Wang","year":"2021","unstructured":"Wang P, Ye Y (2021) Astrocytes in neurodegenerative diseases: a perspective from tauopathy and alpha-synucleinopathy. Life (Basel) 11(9):938. https:\/\/doi.org\/10.3390\/life11090938","journal-title":"Life (Basel)"},{"key":"2371_CR196","doi-asserted-by":"publisher","first-page":"110660","DOI":"10.1016\/j.biopha.2020.110660","volume":"131","author":"Y Wang","year":"2020","unstructured":"Wang Y, Che M, Xin J, Zheng Z, Li J, Zhang S (2020) The role of IL-1\u03b2 and TNF-\u03b1 in intervertebral disc degeneration. Biomed Pharmacother 131:110660. https:\/\/doi.org\/10.1016\/j.biopha.2020.110660","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2371_CR192","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-025-02138-6","volume":"10","author":"F Wang","year":"2025","unstructured":"Wang F, Wang Y, Xiong B, Yang Z, Wang J, Yao Y, Yu L, Fu Q, Li L, Zhang Q (2025a) Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study. Signal Transduct Target therapy 10(1):45","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"2371_CR195","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/13872877251336442","volume":"106","author":"T Wang","year":"2025","unstructured":"Wang T, Jiang H, Zheng R, Zhang C, Ma X, Liu Y (2025b) Trends and research focus on autophagy in Alzheimer\u2019s disease (2003\u20132023): a bibliometric study. J Alzheimers Dis 106(1):5\u201317. https:\/\/doi.org\/10.1177\/13872877251336442","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2371_CR197","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41593-024-01829-7","volume":"28","author":"N Watamura","year":"2025","unstructured":"Watamura N, Foiani MS, Bez S, Bourdenx M, Santambrogio A, Frodsham C, Camporesi E, Brinkmalm G, Zetterberg H, Patel S (2025) In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds. Nat Neurosci 28(2):293\u2013307","journal-title":"Nat Neurosci"},{"issue":"2","key":"2371_CR198","doi-asserted-by":"publisher","first-page":"100989","DOI":"10.1016\/j.jbc.2021.100989","volume":"297","author":"Y Watanabe","year":"2021","unstructured":"Watanabe Y, Sasaki T, Miyoshi S, Shimizu M, Yamauchi Y, Sato R (2021) Insulin-induced genes INSIG1 and INSIG2 mediate oxysterol-dependent activation of the PERK-eIF2alpha-ATF4 axis. J Biol Chem 297(2):100989. https:\/\/doi.org\/10.1016\/j.jbc.2021.100989","journal-title":"J Biol Chem"},{"key":"2371_CR199","doi-asserted-by":"crossref","unstructured":"Wen Y, Wang S, Chen Y, Yu H (2025) Prediction of Alzheimer\u2019s disease progression from mild. Cognitive Impairment Using Polygenic Risk Scores","DOI":"10.21203\/rs.3.rs-7812084\/v1"},{"key":"2371_CR200","unstructured":"Wiegand J-P (2018) The influence of aging and parkinson\u2019s disease on neural oscillations associated with memory consolidation. The University of Arizona"},{"key":"2371_CR201","doi-asserted-by":"publisher","first-page":"1585711","DOI":"10.3389\/fpubh.2025.1585711","volume":"13","author":"Z Xiaopeng","year":"2025","unstructured":"Xiaopeng Z, Jing Y, Xia L, Xingsheng W, Juan D, Yan L, Baoshan L (2025) Global Burden of Alzheimer\u2019s disease and other dementias in adults aged 65 years and older, 1991\u20132021: population-based study. Front Public Health 13:1585711. https:\/\/doi.org\/10.3389\/fpubh.2025.1585711","journal-title":"Front Public Health"},{"issue":"6156","key":"2371_CR203","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O\u2019Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342(6156):373\u2013377. https:\/\/doi.org\/10.1126\/science.1241224","journal-title":"Science"},{"issue":"2","key":"2371_CR202","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/biology12020152","volume":"12","author":"J Xie","year":"2023","unstructured":"Xie J, Xie L, Wei H, Li XJ, Lin L (2023) Dynamic Regulation of DNA Methylation and Brain Functions. Biology (Basel) 12(2):152. https:\/\/doi.org\/10.3390\/biology12020152","journal-title":"Biology (Basel)"},{"key":"2371_CR204","doi-asserted-by":"publisher","first-page":"1554813","DOI":"10.3389\/fneur.2025.1554813","volume":"16","author":"Y Xu","year":"2025","unstructured":"Xu Y, Yin H, Li L, Wang X, Hou Q (2025) Covert cerebrospinal fluid dynamics dysfunction: evolution from conventional to innovative therapies. Front Neurol 16:1554813. https:\/\/doi.org\/10.3389\/fneur.2025.1554813","journal-title":"Front Neurol"},{"issue":"2008","key":"2371_CR205","first-page":"663694","volume":"20252007","author":"R Yang","year":"2025","unstructured":"Yang R, Li Y, Zhao X, Wang L, Wu J, Sima J (2025) AAV-based temporal APOE4-to-APOE2 replacement reveals rebound adaptation and RAB24-mediated A\u03b2 and cholesterol dysregulation. bioRxiv 20252007(2008):663694","journal-title":"bioRxiv"},{"issue":"2","key":"2371_CR206","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M (2016) TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91(2):328\u2013340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015","journal-title":"Neuron"},{"issue":"26","key":"2371_CR207","doi-asserted-by":"publisher","first-page":"E3773","DOI":"10.1073\/pnas.1604519113","volume":"113","author":"Y Yin","year":"2016","unstructured":"Yin Y, Gao D, Wang Y, Wang ZH, Wang X, Ye J, Wu D, Fang L, Pi G, Yang Y, Wang XC, Lu C, Ye K, Wang JZ (2016) Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV\/CREB signaling. Proc Natl Acad Sci U S A 113(26):E3773\u20133781. https:\/\/doi.org\/10.1073\/pnas.1604519113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2371_CR208","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41593-023-01355-y","volume":"26","author":"Z Yin","year":"2023","unstructured":"Yin Z, Herron S, Silveira S, Kleemann K, Gauthier C, Mallah D, Cheng Y, Margeta MA, Pitts KM, Barry JL, Subramanian A, Shorey H, Brandao W, Durao A, Delpech JC, Madore C, Jedrychowski M, Ajay AK, Murugaiyan G, Butovsky O (2023) Identification of a protective microglial state mediated by miR-155 and interferon-gamma signaling in a mouse model of Alzheimer\u2019s disease. Nat Neurosci 26(7):1196\u20131207. https:\/\/doi.org\/10.1038\/s41593-023-01355-y","journal-title":"Nat Neurosci"},{"issue":"12","key":"2371_CR209","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/metabo12121222","volume":"12","author":"HU Zacharias","year":"2022","unstructured":"Zacharias HU, Kaleta C, Cossais F, Schaeffer E, Berndt H, Best L, Dost T, Gl\u00fcsing S, Groussin M, Poyet M (2022) Microbiome and metabolome insights into the role of the gastrointestinal\u2013brain axis in Parkinson\u2019s and Alzheimer\u2019s disease: unveiling potential therapeutic targets. Metabolites 12(12):1222","journal-title":"Metabolites"},{"issue":"11","key":"2371_CR210","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/dna.2014.2738","volume":"34","author":"YD Zhang","year":"2015","unstructured":"Zhang YD, Zhao JJ (2015) TFEB participates in the abeta-induced pathogenesis of Alzheimer\u2019s disease by regulating the autophagy-lysosome pathway. DNA Cell Biol 34(11):661\u2013668. https:\/\/doi.org\/10.1089\/dna.2014.2738","journal-title":"DNA Cell Biol"},{"issue":"1","key":"2371_CR211","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7150\/thno.79535","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao J, Huai J (2023) Role of primary aging hallmarks in Alzheimer s disease. Theranostics 13(1):197","journal-title":"Theranostics"},{"issue":"10","key":"2371_CR212","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/biom14101204","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Huang Y, Cao Y, Yang J (2024) Astrocyte-mediated neuroinflammation in neurological conditions. Biomolecules 14(10):1204. https:\/\/doi.org\/10.3390\/biom14101204","journal-title":"Biomolecules"},{"key":"2371_CR213","unstructured":"Zoltan Ungvari M Obesity-induced cognitive impairment in older adults: a microvascular perspective"},{"issue":"1","key":"2371_CR214","doi-asserted-by":"publisher","first-page":"2270781","DOI":"10.1080\/14756366.2023.2270781","volume":"38","author":"D Zou","year":"2023","unstructured":"Zou D, Liu R, Lv Y, Guo J, Zhang C, Xie Y (2023) Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer\u2019s disease. J Enzyme Inhib Med Chem 38(1):2270781. https:\/\/doi.org\/10.1080\/14756366.2023.2270781","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02371-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:03:35Z","timestamp":1788966215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02371-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":214,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2371"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02371-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}